AbstractObjectivesAstragalus membranaceus has been reported to inhibit immune responses, but its effect on hair loss is not clear. In this study, the effect of A. membranaceus extract (AM) on hair regrowth in C57BL/6 mice with natural hair loss in the telogen phase was investigated.
MethodsMice with natural hair loss were topically treated with 1% AM on the dorsal skin for 2 weeks. Dorsal skin samples were stained with hematoxylin and eosin and probed with an anti-mouse CD8a IgG. The mRNA expression levels of tumor necrosis factor (TNF)-α, interferon (IFN)-γ and interleukin (IL)-4 were measured by reverse transcription polymerase chain reaction and quantitative real-time polymerase chain reaction.
ResultsAM treatment induced hair regrowth in hair loss mice, while control mice suffered continued hair loss. Tapering hair shafts and broken hair follicles were decreased as well as CD8+ T lymphocyte infiltration. In addition, the expressions of TNF-α, IFN-γ and IL-4 were reduced by AM treatment. Also, AM treatment significantly increased the KGF expressions in Hs68 fibroblast cells.
References1. Stenn, KS, & Paus, R. Controls of Hair Follicle Cycling. Physiological Reviews, (2001). 81(1), 449-94.
![]() 2. Min, BG. Diagnosis and treatment of hair & scalp disorders. Hanmi Book, (2005). 21-30.
3. Zoe DD. Cosmetics in dermatology. 2nd. London. Churchill Livingstone;(1995). p. 179-91.
4. Ahn SG, Ji HG, Hwang SM, Jung J, Jang KH. Common Skin Disease. Pacific publisher;(2003). p. 437
5. Korean Dermatology Association. Textbook of Dermatology. 6Th. Seoul. Med book;(2014). p. 551-7.
6. Lee, SH, & Lee, JR. Association of Diffuse Hair loss of Adult Male on Stress, Self-confidence, and Depression. Journal of the Society of Cosmetic Scientists of Korea, (2010). 16(4), 1171-9.
7. Fitzpatrick TB, Wolff K. Fitzpatrick’s dermatology in general medicine. 7Th. NewYork. McGraw-Hill;(2008). p. 766-9.
8. Moustafa, AET, Hassan, I, Essam, AN, & Mai, SAD. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation. Dermatologic Therapy, (2017). 30(1), e12437.
![]() 9. Amin, SS, & Sachdeva, S. Alopecia areata: A review. Saudi Society of Dermatology and Dermatologic Surgery, (2013). 17, 37-45.
![]() 10. Blumeyer, A, Tosti, A, Messenger, A, Reygagne, P, Del Marmol, V, & Spuls, PI, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. Journal der Deutschen Dermatologischen Gesellschaft, (2011). 9(6), 51-7.
![]() 11. Varothai, S, & Bergfeld, WF. Androgenetic Alopecia: An Evidence-Based Treatment Update. American Journal of Clinical Dermatology, (2014). 15(3), 217-30.
![]() ![]() 12. Levy, LL, & Emer, JJ. Female pattern alopecia: current perspectives. International Journal of Women’s Health, (2013). 5, 541-56.
![]() ![]() 13. Yamana, K, Labrie, F, & Luu-The, V. Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and Dutasteride. Hormone Molecular Biology and Clinical Investigation, (2010). 2, 293-9.
![]() 14. Lee, SY, Chun, SW, Kim, JB, & No, BI. A Case of Combination Therapy with Finasteride and Low Dose Dutasteride in the Treatment of Androgenetic Alopecia. Korean Journal of Dermatology, (2017). 55(2), 147-8.
15. Mounsey, AL, & Reed, SW. Diagnosing and treating hair loss. American Family Physician, (2009). 80(4), 356-62.
![]() 16. Eun, HC, Kwon, OS, Yeon, JH, Skin, HS, Kim, BY, & Ro, BI, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study. Journal of the American Academy of Dermatology, (2010). 63, 252-8.
![]() ![]() 17. Choi, GS, & Kim, JH. Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia. Annals of Dermatology, (2016). 28(4), 444-50.
![]() ![]() ![]() 18. Lee, WS, Ahn, HJ, & Kim, YH. The Effect of Coapplication of Capsaicin and Minoxidil on the Murine Hair growth. Korean Journal of Dermatology, (2003). 41(4), 451-60.
19. Zappacosta, AR. Reversal of baldness in patient receiving minoxidil for hypertension. The New England Journal of Medicine, (1980). 303, 1480-1.
![]() 20. Fiedler-Weiss, VC. Potential mechanisms of minoxidil-induced hair growth in alopecia areata. Journal of the American Academy of Dermatology, (1987). 16, 653-6.
![]() ![]() 21. Messenger, AG, & Rundegren, J. Minoxidil: mechanisms of action on hair growth. British Journal of Dermatology, (2004). 150, 186-94.
![]() ![]() 22. Evelyn, YC. Androgenetic alopecia (male pattern hair loss) in the United States: What treatments should primary care providers recommend? Journal of the American Association of Nurse Practitioners, (2013). 25(8), 395-401.
![]() 23. Alkhalifah, A, Alsantali, A, Wang, E, McElwee, KJ, & Shapiro, J. Alopecia areata update. Part II: treatment. Journal of the American Academy of Dermatology, (2010). 62, 191-202.
![]() 24. Olsen, EA, Carson, SC, & Turney, EA. Systemic steroids with or without 2% topical minoxidil in the tretment of alopecia areata. Archives of Dermatology, (1992). 128, 1467-73.
![]() ![]() 25. Chiang, KS, Mesinkovska, NA, Piliang, MP, & Bergfeld, WF. Clinical efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients. Journal of Investigative Dermatology Symposium Proceedings, (2015). 17, 50-5.
![]() 26. Ohtsuki, A, Hasegawa, T, Komiyama, E, Takagi, A, Kawasaki, J, & Ikeda, S. 308-nm Excimer Lamp for the Treatment of Alopecia Areata: Clinical Trial on 16 Cases. Indian Journal of Dermatology, (2013). 58(4), 326.
![]() ![]() ![]() 27. Munck, A, Gavazzoni, MF, & Trüeb, RM. Use of low-level laser therapy as monotherapy or concomitant therapy for male and female androgenetic alopecia. Canadian Medical Association Journal, (2013). 185(18), 1579-85.
![]() ![]() ![]() 28. Fukuoka, H, & Suga, H. Hair Regeneration Treatment Using Adipose-Derived Stem Cell Conditioned Medium: Follow-up With Trichograms. Eplasty, (2015). 15, e10.
![]() ![]() 29. Zawar, VP, & Karad, GM. Liquid nitrogen cryotherapy in recalcitrant alopecia areata: a study of 11 patients. International Journal of Trichology, (2016). 8, 15-20.
![]() ![]() ![]() 30. Khatu, SS, More, YE, Gokhale, NR, Chavhan, DC, & Bendsure, N. Platelet-rich plasma in androgenic alopecia: myth or an effective tool. Journal of Cutaneous and Aesthetic Surgery, (2014). 7(2), 107-10.
![]() ![]() ![]() 31. Lee WG. Sinpyeonsomunjipju. Seoul. Daeseongmunhwasa;(1994). p. 894
32. Kwak AC. Hwangjenaegyeong yeongchugyojueoseok. Busan. Iljungsa;(1993). 123:p. 213
33. Gal H. Galhongjuhubigeupbang. Beijing. Inminwi-saengchulpansa;(1996). p. 196
34. So WB. Sossijebyeongwonhuchongnon. Shanghai. Soinchulpansa;(1980). p. 695-6.
35. Son SM. Bigeupcheongeumyobang. Seoul. Deseongmunhwasa;(1984). p. 434-5.
36. Jin SG. Oegwajeongjong. Beijing. Inminwisaengchulpansa;(1983). p. 256
38. Gao, J, Liu, H, Xie, Y, Zhao, H, Xie, Z, & Zhong, Z. Clinical observation of the therapy of catgut embedding and moxibustion on androgenetic alopecia. Modern Journal of Integrated Traditional Chinese and Western Medicine, (2013). 22(1), 8-15.
39. Lin, KR, Jiang, YF, & Yu, AS. Clinical observation of Chinese comprehensive therapy on androgenetic alopecia of damp and heat in the spleen and the stomach pattern. Shanghai Journal of Traditional Chinese Medicine, (2014). 48(8), 53-6.
40. Yang SS. Junguiimsangdaejeon. Seoul. Daeseongchulpansa;(1988). p. 912
41. Chen GT. Siryongjungseouigyeolhapjindan-chiryohak. Busan. Iljungsa;(1992). p. 1508
42. Gu BK. Junguioegwahak. Shanghai. Sanghaegwahakg-isulchulpansa;(1985). p. 309-12.
43. All oriental medicine university bonchohak teacher. Bonchohak. Seoul. Yunglimsa;(2007). p. 576-8.
44. Kim, SH, Jun, YM, Lim, JJ, Kim, SH, Chung, IM, & Kim, EH. Variation of Astragalosides Contents in Cultivated Astragalus membranaceus. Korean Journal of Medicinal Crop Science, (2012). 20(5), 372-80.
![]() 45. Bai, F, Makino, T, Kono, K, Nagatsu, A, Ono, T, & Mizukami, H. Calycosin and formononetin from astragalus root enhance dimethylarginine dimethylaminohydrolase 2 and nitric oxide synthase expressions in Madin Darby Canine Kidney II cells. Journal of Natural Medicines, (2013). 67(4), 782-9.
![]() ![]() 46. Park, CI. Study on Effects of Anti-oxidant and Viscoelastic on Emulsion by the Extract of Astragalus membranaceus. The Korea Journal of Herbology, (2012). 27(2), 93-7.
![]() 47. Baek, NI, Kim, YS, Kyung, JS, & Park, KH. Isolation of anti-hepatotoxic agent from the root of Astragalus membranacus. Korean Journal of Pharmacognosy, (1996). 27, 111-6.
48. Hikino, H, Funayama, S, & Endo, K. Hypotensive principles of Astragalus and Hedysarum roots. Planta Medica, (1976). 30, 297-302.
![]() ![]() 49. Zang, YD, Wang, YL, Shen, JP, & Li, DX. Hypotensive and anti-inflammatory effects of Astragalus saponin 1. Acta Pharmacologica Sinica, (1984). 19, 333-7.
50. Kim, JH, Kim, MH, Yang, GS, Huh, YB, Kim, SH, & Yang, WM. Effects of topical application of Astragalus membranaceus on allergic dermatitis. Immunopharmacology and Immunotoxicology, (2012). 35(1), 151-6.
![]() ![]() 51. Kim, MH, Kim, SH, & Yang, WM. Beneficial Effects of Astragaloside IV for Hair Loss via Inhibition of Fas/Fas L-Mediated Apoptotic Signaling. PLoS One, (2014). 9(3), e92984.
![]() ![]() ![]() 52. Paus, R, Ito, N, Takigawa, M, & Ito, T. The hair follicle and immune privilege. Journal of Investigative Dermatology Symposium Proceedings, (2003). 8(2), 188-94.
![]() 53. Ansel, J, Perry, P, & Brown, J. Cytokine modulation of keratinocyte cytokines. Journal of Investigative Dermatology, (1990). 94(6), 1015-75.
![]() ![]() 55. Philpott, MP, Sanders, DA, Bowen, J, & Kealey, T. Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-α in alopecia areata. British Journal of Dermatology, (1996). 135(6), 942-8.
![]() ![]() 56. Hoffmann, R, Eicheler, W, Huth, A, Wenzel, E, & Happle, R. Cytokines and growth factors influence hair growth in vitro: Possible implications for the pathogenesis and treatment of alopecia areata. Archives of Dermatological Research, (1996). 288, 153-6.
![]() ![]() 57. Gilhar, A, Etzioni, A, Assy, A, & Eidelman, S. Response of grafts from patients with alopecia areata transplanted onto nude mice, to administration of interferon-gamma. Clinical Immunology and Immunopathology, (1993). 66, 120-6.
![]() ![]() 58. Sato-Kawamura, M, Aiba, S, & Tagami, H. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata. Archives of Dermatological Research, (2003). 294(12), 536-43.
![]() ![]() 59. Freyschmidt-Paul, P, McElwee, KJ, Hoffmann, R, Sundberg, JP, Vitacolonna, M, & Kissling, S, et al. Interferon-gamma-deficient mice are resistant to the development of alopecia areata. British Journal of Dermatology, (2006). 155(3), 515-21.
![]() ![]() 60. Teraki, Y, Imanishi, K, & Shiohara, T. Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis). Acta Dermato-Venereologica, (1996). 76(6), 421-3.
![]() 61. Attia, EA, El Shennawy, D, & Sefin, A. Serum Interleukin-4 and Total Immunoglobulin E in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing. Dermatology Research and Practice, (2010). 2010, 1-6.
![]() 62. Hom, DB. Growth factors in wound healing. Otolaryngologic Clinics of North America, (1995). 28(5), 933-53.
![]() |
|